Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection.
about
Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining ConditionsLung cancer in HIV-infected patients in the combination antiretroviral treatment eraEpidemic of lung cancer in patients with HIV infectionHIV infection, aging, and immune function: implications for cancer risk and preventionFindings in asymptomatic HIV-infected patients undergoing chest computed tomography testing: implications for lung cancer screening.Smoking Cessation Interventions in HIV-Infected Adults in North America: A Literature Review.AIDS and non-AIDS severe morbidity associated with hospitalizations among HIV-infected patients in two regions with universal access to care and antiretroviral therapy, France and Brazil, 2000-2008: hospital-based cohort studiesSingle-institutional experience of clinicopathological analysis and treatment for lung cancer patients with human immunodeficiency virus infection.A Review of the Literature Concerning HIV and Cigarette Smoking: Morbidity and Mortality, Associations with Individual- and Social-Level Characteristics, and Smoking Cessation Efforts.Profiles of Risk Among HIV-Infected Youth in Clinic SettingsRisk of cancer among HIV-infected patients from a population-based nested case-control study: implications for cancer prevention.Lung cancer incidence and survival among HIV-infected and uninfected women and men.Determinants of Smoking and Quitting in HIV-Infected Individuals.Tobacco Use, Use Disorders, and Smoking Cessation Interventions in Persons Living With HIV.Pathogenesis of HIV and the lungEffects of smoking on non-AIDS-related morbidity in HIV-infected patients.Tobacco use and cessation in HIV-infected individualsRisk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy.Lung Malignancies in HIV Infection.Epidemiology of head and neck squamous cell cancer among HIV-infected patients.Lung cancer in persons with HIV.Immunological and infectious risk factors for lung cancer in US veterans with HIV: a longitudinal cohort study.Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.Trends in cancer diagnoses and survival among persons with AIDS in a high HIV prevalence urban area.Investigating Barriers in HIV-Testing Oncology Patients: The IBITOP Study, Phase I.A multi-institutional study of clinicopathological features and molecular epidemiology of epidermal growth factor receptor mutations in lung cancer patients living with human immunodeficiency virus infection.Lung Cancer Mortality Associated With Smoking and Smoking Cessation Among People Living With HIV in the United States.HIV-associated lung cancer: ambiguities and challenges.Comment on 'Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection'.HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers.
P2860
Q26740117-6B5ED56A-3090-4540-9151-815E06EBD984Q26769769-7C408FC1-8D83-4698-8E27-E00D8E664ED8Q27000028-62557B18-3280-4179-8ED5-8ADA712ABCB5Q27004165-0BE21A0A-0B24-410E-8BC1-63FF53D2382FQ33600046-4C152824-DD1C-4BE6-92BC-F4B6CA2234DEQ33613909-41960015-4E95-49EB-921C-EC44ACF43BEBQ33656320-CBEC3C65-4937-41BC-A656-0C3FA02CDB89Q33684235-FD2DA527-0A43-440A-AF8C-45C49DDAA3B7Q33704159-9A91FFF4-9590-4B4D-BCEE-97437F259B5FQ35079623-475874B6-F155-42B1-B9E8-754AD3ECA3C9Q35204230-CEDDBFD2-9AAD-40F4-A96E-D8B4770FB94AQ35688460-72926D87-76CB-4E5F-BFE3-ED344E456C10Q35995595-65430848-F189-4BAD-8FE3-ED33EAA5E13DQ36275850-406ED5C7-C9AB-4BBC-A822-1F19B82861CAQ36594970-878A6B13-4413-485E-87CE-5064CF08F41EQ36946246-BB591D7B-BB42-4A82-8C19-B2AD9B45AB62Q37041288-E11D1911-8357-48EC-89D1-43AD981E4127Q37416478-44E44915-D2FA-43C9-8BCD-D35771E9835CQ37478443-A70535AC-E02E-4025-A974-018B43883560Q37722577-7CB9EA4A-A63E-44BC-A3D5-CD31BEC5E876Q38949456-9716EA4E-E61A-4037-A49A-814CE67379A4Q39132282-CE025D76-5FC8-4568-8CB8-3B382439D7CEQ39508906-5F1AC7D4-8053-4527-ABAB-0A3D97E12DD9Q40259517-0542AFC0-4338-433C-B4E7-E9621697AE05Q40605849-AE94B5F2-EC96-418F-A199-EFD52FAF5129Q41393034-96FBDF59-C53E-4AD6-87D4-8547254DCDE2Q41925024-9BE444A3-1D9D-4821-ACD9-AE4D9F3A8880Q43031495-C8A9DA70-2B36-4BD7-8E88-864EAC54253BQ43185823-12097591-D6D4-4D9C-B741-7959A75C6969Q47549582-59D63102-245F-457C-B523-60A69ED5D8FD
P2860
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Lung cancer in the Swiss HIV C ...... iency and pulmonary infection.
@ast
Lung cancer in the Swiss HIV C ...... iency and pulmonary infection.
@en
type
label
Lung cancer in the Swiss HIV C ...... iency and pulmonary infection.
@ast
Lung cancer in the Swiss HIV C ...... iency and pulmonary infection.
@en
prefLabel
Lung cancer in the Swiss HIV C ...... iency and pulmonary infection.
@ast
Lung cancer in the Swiss HIV C ...... iency and pulmonary infection.
@en
P2093
P2860
P50
P356
P1476
Lung cancer in the Swiss HIV C ...... iency and pulmonary infection.
@en
P2093
C Bouchardy
E Bernasconi
F Schöni-Affolter
G M Clifford
G Wandeler
P2860
P2888
P304
P356
10.1038/BJC.2011.558
P407
P577
2012-01-12T00:00:00Z